How to Buy Repligen Stock
Repligen Corp
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.
Repligen stock last closed at $166.58, up 0.56% from the previous day, and has increased 12.07% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.24 percentage points. Repligen stock is currently +50.82% from its 52-week low of $110.45, and -21.1% from its 52-week high of $211.13.
As of Apr 26, 2024, there are 55.77M shares of RGEN outstanding. The market capitalization of RGEN is $9.29B. In the last 24 hours, 341,269 RGEN shares were traded.
How to Buy Repligen Stock
Not sure how to invest in Repligen stock? Here's how.
- Choose where to buy Repligen stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Repligen stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your method of payment and add your info.
- Research Repligen stock: The Repligen ticker symbol is RGEN. Is Repligen stock a good investment? Should you buy shares of RGEN? How do RGEN's underlying business fundamentals look? Do top analysts think Repligen is a good buy? Why has RGEN's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if RGEN is a good stock to buy).
- Place your RGEN buy order: Decide if you will purchase RGEN shares at the current market price or use a limit order to buy RGEN stock at a given price.
- Get the latest scoop on your RGEN position: Create a watchlist to get the latest news on your position in Repligen shares.
Step 1: Choose where to buy Repligen stock
You need a brokerage account in order to access the NASDAQ market and buy RGEN stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in RGEN today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the best app for stock investing, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help transferring funds into your new investment account.
Step 4: Research Repligen stock
After you have selected the best place to buy Repligen stock, it's important to analyze their stock before you invest, so you actually comprehend the risk and upside.
Repligen Numbers
RGEN Zen Score
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on RGEN's stock page.
What is the fair value of RGEN stock?
Analysts use many financial metrics, analyses, models, and charts to gauge RGEN's fair value.
Using relative valuations methods:
- RGEN may be overvalued based on its P/E ratio of 222.11x, relative to Medical Instruments & Supplies industry P/E ratio of 48.29x
- RGEN could be overvalued based on its P/B ratio of 4.71x, relative to Medical Instruments & Supplies industry P/B ratio of 3.53x
- RGEN may be overvalued based on its PEG ratio of 1.6x
You can access additional valuation analysis on RGEN's stock here.
A quick look at RGEN Financials
Pros:
- There are more short-term assets than long-term liabilities on the RGEN balance sheet.
- RGEN earnings of $66.08M is not sufficient to cover its interest payments.
- There are more short-term assets than short-term liabilities on the RGEN balance sheet.
Cons:
- RGEN has a relatively high debt to equity ratio of 0.43.
- Total RGEN debt is higher than 5 years ago, relative to shareholder equity.
- RGEN's operating cash flow of $113.92M allows it to safely service it's debt of $711.80M.
- RGEN profit margin has gone down from 23.2% to 6.5% in the past year.
Is it a good time to buy RGEN stock, according to Wall Street analysts?
Out of 5 sell side analysts who track RGEN, the consensus analyst rating on Repligen is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Repligen stock forecast page.
RGEN Momentum
How are RGEN Revenues/Earnings doing?
Last year, RGEN earnings were $41.58M. In the past five year, RGEN's earnings have grown by 14.57% per year. This was slower than the Medical Instruments & Supplies industry average of 16.9%.
Last year, RGEN revenue was $638.76M. Over the past five year, RGEN's revenue has increased by 26.91% per year. This was faster than the Medical Instruments & Supplies industry average of 9.46%.
Learn more about RGEN's earnings and revenue performance here.
Are RGEN insiders buying or selling the stock?
In the past 12 months, insiders at RGEN have sold more shares than they have bought.
James Bylund, Chief Operating Officer of RGEN, was the latest RGEN insider to sell. They sold $81,229.80 worth of RGEN stock on Apr 2, 2024.
Learn more about who owns RGEN stock here.
Does RGEN provide a stable income stream?
No, Repligen doesn't provide an income stream by paying out dividends.
What others are saying about RGEN
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your RGEN buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you want more info about buying stocks on eToro, click the helpful video below:
Step 6: Get the latest scoop on your RGEN position
Now that you own some RGEN stock, you'll want to keep up with your stock purchase.
Create a watchlist to monitor your RGEN stock.
RGEN Feed
How to Buy Stock in Repligen
To summarize, here are the 6 steps to buy stock in Repligen:
- Choose where to buy Repligen stock
- Sign up for your brokerage account
- Deposit funds into your investment account
- Research Repligen stock
- Place your RGEN buy order
- Get the latest scoop on your RGEN position
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Repligen, hit the button below to create your watchlist.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.